Immunic Therapeutics
GermanyEntry
2016
Hold
3yr
Exit
2019
Who owns Immunic Therapeutics?
Immunic Therapeutics was owned by bmp Ventures AG through IBG Innovationsfonds (2015 vintage) from 2016 to 2019, exited via IPO. Across its history, Immunic Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.
Buyer identity available on Pro.
Hand-verified · updated 2026-07-03
Most recent investor
bmp Ventures AGIBG Innovationsfonds · 2015 · Evergreen
2 ownership periods · full history below
Key facts
HQGermany
SectorBiotech
StatusAcquired
Key takeaways
- ·Fully exited in 2019.
- ·Average hold across 2 realized cycles: 3 years.
Ownership history
2 ownership periods · co-invest detected
Exited
Last exited in 2019 to .
Co-invest · 2 holders · 2016 · 2019
More from IBG Innovationsfonds
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USTrack Immunic Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Immunic Therapeutics?
6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Immunic Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue